Location: San Francisco, CA, USA
Start Date: 09/13/2018
End Date: 09/14/2018
AllSeq Discount Code: asp/mp/4bio/15 (15%)
Twitter Hashtag: #4BIO
Global Engage is pleased to announce the 4BIO Summit: USA. Combining the 4th qPCR & Digital PCR Congress and the 3rd Microfluidics Congress, this summit will bring together over 180 industry and academic experts and will provide an interactive networking forum as well as the opportunity to keep up to date with the cutting edge of research in your field.
qPCR & Digital PCR Congress
Designed for academic experts working in areas such as molecular biology/diagnostics, liquid biopsies, gene expression, genomics, biomarkers, pathogen detection, and miRNA analysis, these tracks will examine the latest developments, opportunities and applications of both dPCR and qPCR through case studies across diverse areas such as oncology, infectious diseases, vaccines, clinical applications, microbiology, and other novel applications. With increasing numbers of real-time PCR users purchasing digital PCR due to the reduction in its cost, absolute quantification, improved sensitivity, precision and greater robustness; and with the qPCR and Digital PCR market predicted to grow to $4.94 billion by 2021, this conference provides a timely opportunity to learn firsthand about dPCR whilst also keeping up to date with latest developments and strategies in qPCR. The conference will provide an interactive networking forum to both further develop and answer your queries through a vibrant exhibition room full of technology providers showcasing their technologies and other solutions, poster presentation sessions, and expert led case study presentations from a 30-strong speaker faculty examining topics on 3 separate tracks.
At the intersection of engineering, physics, chemistry, nanotechnology and biotechnology, microfluidics holds great promise for the advancement of human healthcare. As a rapidly developing are of research, this technology looks to revolutionize the way patients are diagnosed, monitored and treated, and is unlocking the potential for reduced reagent consumption and thus, cost. With two dedicated tracks, these interactive sessions bring together experts working across multiple key fields in microfluidics, and will showcase case studies examining the latest advancements in the development of microfluidic devices and their application in diagnostics and disease monitoring and detection. Talks will cover lab-on-a- chip fabrication, development of paper based systems, and droplet, digital and acousto-microfluidics, as well as point of-care diagnostics, single cell analysis, circulating tumor cell capture and analysis, high throughput screening, and next generation micro and nanofluidics. This meeting will allow you to keep up to date with the cutting edge of research and the opportunity to make lasting connections with academics, entrepreneurs and businesses in your field.
Numerous presentations at both Congresses incorporate the important role that sequencing plays, and how it is being used to compliment the other technologies.
With an expert speaker line-up, including leaders in the field such as Hestia Mellert, Director, Molecular Development, Biodesix Inc., and Carl Wittwer, Professor of Pathology, Univeristy of Utah, you cannot afford to miss out on this event.
Find out more and register your interest here: https://goo.gl/oPrsj7